Additionally, diminished serum adiponectin levels in psoriasis patients, along with a negative correlation with BMI, TNF-α, and IL-6 levels, suggest a potential anti-inflammatory role in inhibiting adipocyte adipogenesis and Th17 cell-mediated inflammation (53–56). This evidence concerns the gene ADIPOQ and psoriasis.